Celgene Corp. (CELG)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 702.45m
  • Volume: 0

Celgene Corp. Overview

Celgene engages in the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases in the United States. It operates in two segments: Human Pharmaceuticals and Stem Cell Therapies.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite, S&P 100
ISIN: US1510201049

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Celgene Corp. Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 702.45m

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page